Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Calcium carbonate + fluoride** is an oral fixed-dose mineral supplement combination represented by the marketed product Florical, which supplies calcium carbonate from oyster shell and sodium fluoride in a capsule. Calcium provides an absorbable source of calcium for normal skeletal mineralization and neuromuscular physiology, while fluoride can incorporate into hydroxyapatite-containing mineral to support formation of more acid-resistant fluorapatite in dental enamel and may affect bone mineralization. Florical is listed by its manufacturer as a dietary supplement, not as an FDA-approved prescription drug; its current label specifies 364 mg calcium carbonate and 8.3 mg sodium fluoride per capsule, equivalent to 145 mg calcium and 3.75 mg fluoride. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=70faa127-b6c8-493c-9aa9-16885bbfca80))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium carbonate + fluoride.